Pluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming ConferencesGlobeNewsWire • 8h
Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market ReportGlobeNewsWire • 03/21/24
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug ManufacturingGlobeNewsWire • 03/14/24
Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell CultivationGlobeNewsWire • 03/11/24
Pluri's Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 GoalsGlobeNewsWire • 02/28/24
Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee CrisisGlobeNewsWire • 01/23/24
Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing OrganizationGlobeNewsWire • 01/08/24
Pluri's PLX-R18 Increases Blood Cell Counts and Reduces Need for Transfusions in a Phase I Study: Results Published in Nature Bone Marrow TransplantationGlobeNewsWire • 08/16/23
Pluri Announces Appointment of Entrepreneur Lorne Abony to Board of DirectorsGlobeNewsWire • 07/13/23
U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluri's PLX-R18 in Conjunction with U.S. DoD as a Medical Countermeasure for Hematopoietic Acute Radiation SyndromeGlobeNewsWire • 07/11/23
Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale Production of Cell-Based ProductsGlobeNewsWire • 04/27/23
Israel's Ministry of Labor Names Pluri as Winner of the 2022 Egalitarian Employment Award for its Commitment to Gender Diversity and Pay EquityGlobeNewsWire • 03/13/23
Pluri CEO Issues Letter to Shareholders Summarizing the Strategy Change and Progress in 2022 and Announcing Food Tech Joint Venture Proof of ConceptGlobeNewsWire • 12/22/22
Pluri Prices $8.2 million Private Placement Offerings Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 12/15/22
Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaboration, Cost Reduction in line with New Strategy and Financial UpdatesGlobeNewsWire • 09/29/22
€7.5 Million Granted to Collaborative PROTO Project led by Charité to Study Pluri's PLX-PAD Cells for Osteoarthritis TreatmentGlobeNewsWire • 09/06/22